Company research
BALCHEM CORP
CIK 9326Updated Sep 27, 2026
SecurityBCPC · NASDAQ · equity
BCPC price & chart
Loading TradingView…
NASDAQ:BCPC on TradingView ↗About the company
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-ofthe-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
11-K filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,686,252,000Source | 1,575,371,000Source | 1,597,211,000Source | 1,624,512,000Source |
| Property, Plant and Equipment, NetUSD | 306,648,000Source | 282,154,000Source | 276,039,000Source | 271,355,000Source |
| GoodwillUSD | 816,375,000Source | 780,030,000Source | 778,907,000Source | 769,509,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 74,570,000Source | 49,515,000Source | 64,447,000Source | 66,560,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 143,596,000Source | 119,662,000Source | 125,284,000Source | 131,578,000Source |
| Inventory, NetUSD | 131,449,000Source | 130,802,000Source | 109,521,000Source | 119,668,000Source |
| Assets, CurrentUSD | 365,614,000Source | 313,770,000Source | 314,242,000Source | 335,803,000Source |
| Operating Lease, Right-of-Use AssetUSD | 14,672,000Source | 15,320,000Source | 17,763,000Source | 17,094,000Source |
| Other Assets, NoncurrentUSD | 18,134,000Source | 17,317,000Source | 16,947,000Source | 15,118,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 428,839,000Source | 425,458,000Source | 543,227,000Source | 686,228,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 2,139,000Source | 2,170,000Source | 2,152,000Source | 2,145,000Source |
| Additional Paid in CapitalUSD | 92,331,000Source | 173,997,000Source | 145,653,000Source | 128,806,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,121,396,000Source | 997,493,000Source | 897,488,000Source | 814,487,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 41,547,000Source | -23,747,000Source | 8,691,000Source | -7,154,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,257,413,000Source | 1,149,913,000Source | 1,053,984,000Source | 938,284,000Source |
| Liabilities and EquityUSD | 1,686,252,000Source | 1,575,371,000Source | 1,597,211,000Source | 1,624,512,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 176,384,000Source | 157,685,000Source | 148,491,000Source | 140,042,000Source |
| Operating Lease, Liability, CurrentUSD | 3,614,000Source | 3,134,000Source | 3,949,000Source | 3,796,000Source |
| Operating Lease, Liability, NoncurrentUSD | 11,324,000Source | 12,967,000Source | 14,601,000Source | 13,806,000Source |
| Deferred Income Tax Liabilities, NetUSD | 54,143,000Source | 43,722,000Source | 52,046,000Source | 62,784,000Source |
| Other Liabilities, NoncurrentUSD | — | — | — | 26,814,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 49,288,000Source | 43,750,000Source | 40,855,000Source | 36,745,000Source |
| Deferred Tax Liabilities, NetUSD | 54,143,000Source | 43,722,000Source | 52,046,000Source | 62,784,000Source |
| Dividends Payable, CurrentUSD | 31,044,000Source | 28,510,000Source | 25,717,000Source | 23,129,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 45,690,000Source | 47,973,000Source | 54,935,000Source | 51,848,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 18,057,000Source | 16,675,000Source | 16,052,000Source | 13,224,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 20,853,000Source | -5,582,000Source | -6,969,000Source | 3,618,000Source |
| Increase (Decrease) in InventoriesUSD | -3,635,000Source | 22,791,000Source | -10,530,000Source | 7,804,000Source |
| Deferred Income Tax Expense (Benefit)USD | 6,262,000Source | -6,779,000Source | -10,814,000Source | -8,362,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 216,556,000Source | 181,999,000Source | 183,761,000Source | 138,536,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 323,000Source | 24,164,000Source | 1,252,000Source | 365,780,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -43,891,000Source | -59,736,000Source | -34,813,000Source | -416,014,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | 49,086,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 107,636,000Source | 5,682,000Source | 4,469,000Source | 35,423,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -152,810,000Source | -133,815,000Source | -153,321,000Source | 246,679,000Source |
| Dividends paid | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 25,055,000Source | -14,932,000Source | -2,113,000Source | -36,679,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 74,570,000Source | 49,515,000Source | 64,447,000Source | 66,560,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 10,603,000Source | 17,697,000Source | 25,933,000Source | 11,879,000Source |
| Income Taxes Paid, NetUSD | 37,749,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 5,200,000Source | -3,380,000Source | 2,260,000Source | -5,880,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | 288,000Source | 287,000Source | 287,000Source | 335,000Source |
| Amortization of Intangible AssetsUSD | 16,993,000Source | 19,244,000Source | 28,035,000Source | 27,271,000Source |
| DepreciationUSD | 28,199,000Source | 28,211,000Source | 26,373,000Source | 24,033,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | -2,520,000Source | 6,547,000Source |
| Dividends Payable, CurrentUSD | 31,044,000Source | 28,510,000Source | 25,717,000Source | 23,129,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | -343,000Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | 58,000Source | -1,664,000Source | -7,031,000Source | — |
| General and Administrative ExpenseUSD | 67,423,000Source | 67,588,000Source | 53,417,000Source | 55,665,000Source |
| GoodwillUSD | 816,375,000Source | 780,030,000Source | 778,907,000Source | 769,509,000Source |
| Income Tax Expense (Benefit)USD | 44,185,000Source | 37,978,000Source | 28,718,000Source | 28,382,000Source |
| Net Income (Loss) Attributable to ParentUSD | 154,845,000Source | 128,475,000Source | 108,543,000Source | 105,367,000Source |
| Nonoperating Income (Expense)USD | -10,296,000Source | -16,456,000Source | -21,932,000Source | -11,437,000Source |
| Operating ExpensesUSD | 161,307,000Source | 153,297,000Source | 142,863,000Source | 135,265,000Source |
| Other Nonoperating Income (Expense)USD | -77,000Source | 72,000Source | 681,000Source | -1,169,000Source |
| Payments of Financing CostsUSD | — | 0Source | 0Source | 1,232,000Source |
| Proceeds from Stock Options ExercisedUSD | 9,307,000Source | 17,228,000Source | 5,242,000Source | 3,212,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | — | 521,000Source | 7,764,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,037,161,000Source | 953,684,000Source | 922,439,000Source | 942,358,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | 209,326,000Source | 182,909,000Source | 159,193,000Source | 145,186,000Source |
| Other Nonoperating Income (Expense)USD | -77,000Source | 72,000Source | 681,000Source | -1,169,000Source |
| Income Tax Expense (Benefit)USD | 44,185,000Source | 37,978,000Source | 28,718,000Source | 28,382,000Source |
| Net Income (Loss) Attributable to ParentUSD | 154,845,000Source | 128,475,000Source | 108,543,000Source | 105,367,000Source |
| Earnings Per Share, BasicUSD per share | 4.8Source | 3.97Source | 3.38Source | 3.29Source |
| Earnings Per Share, DilutedUSD per share | 4.75Source | 3.93Source | 3.35Source | 3.25Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 32,265,000Source | 32,332,000Source | 32,108,000Source | 32,019,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 32,604,000Source | 32,718,000Source | 32,448,000Source | 32,393,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 16,993,000Source | 19,244,000Source | 28,035,000Source | 27,271,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0.96Source | 0.87Source | — | — |
| General and Administrative ExpenseUSD | 67,423,000Source | 67,588,000Source | 53,417,000Source | 55,665,000Source |
| Gross ProfitUSD | 370,633,000Source | 336,206,000Source | 302,056,000Source | 280,451,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 173,022,000Source | — | — | — |
| Interest Income (Expense), NetUSD | — | — | -22,613,000Source | -10,268,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -10,219,000Source | -16,528,000Source | — | — |
| Nonoperating Income (Expense)USD | -10,296,000Source | -16,456,000Source | -21,932,000Source | -11,437,000Source |
| Operating ExpensesUSD | 161,307,000Source | 153,297,000Source | 142,863,000Source | 135,265,000Source |
| Research and Development ExpenseUSD | 18,510,000Source | 16,793,000Source | 15,049,000Source | 12,191,000Source |
| Selling ExpenseUSD | 75,374,000Source | 68,916,000Source | 74,397,000Source | 67,409,000Source |
Filing attachments
ef20061036_ex99-1.htm · 8-K · 2025-12-10
EX-99.1 2 ef20061036_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Balchem Corporation Announces Dividend Montvale, New Jersey. December 10, 2025. Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2025, its Board of Directors declared a dividend on its shares of common stock equal to $0.96 per share on the Company’s issued and outstanding Common Stock, to be payable on January 20, 2026 to stockholders of record at the close of business on December 23, 202…
Read attachment ↗